thiotepa has been researched along with Immunologic Deficiency Syndromes in 4 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Excerpt | Relevance | Reference |
|---|---|---|
| "X-linked EDA-ID1 (ectodermal dysplasia, anhidrotic, with immunodeficiency 1, Online Mendelian Inheritance in Man [OMIM] 300291), or NEMO (nuclear factor kappa B essential modulator) deficiency syndrome, is caused by mutations in the IKBKG/NEMO gene." | 1.56 | Successful Allogeneic Stem Cell Transplantation in Nuclear Factor-Kappa B Essential Modulator Deficiency Syndrome After Treosulfan-Based Conditioning: A Case Report. ( Bąbol-Pokora, K; Dąbrowska-Leonik, N; Frączkiewicz, J; Gul, K; Janeczko-Czarnecka, M; Kałwak, K; Martuszewski, A; Mielcarek-Siedziuk, M; Młynarski, W; Nowak, M; Paluszkiewicz, P; Salamonowicz-Bodzioch, M; Sierżęga-Staykov, K; Ussowicz, M; Wawrzyniak-Dzierżek, E; Wolska-Kuśnierz, B, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martuszewski, A | 1 |
| Paluszkiewicz, P | 1 |
| Sierżęga-Staykov, K | 1 |
| Wawrzyniak-Dzierżek, E | 1 |
| Salamonowicz-Bodzioch, M | 1 |
| Frączkiewicz, J | 1 |
| Janeczko-Czarnecka, M | 1 |
| Mielcarek-Siedziuk, M | 1 |
| Nowak, M | 1 |
| Dąbrowska-Leonik, N | 1 |
| Wolska-Kuśnierz, B | 1 |
| Gul, K | 1 |
| Bąbol-Pokora, K | 1 |
| Młynarski, W | 1 |
| Kałwak, K | 1 |
| Ussowicz, M | 1 |
| Rastogi, N | 1 |
| Katewa, S | 1 |
| Thakkar, D | 1 |
| Kohli, S | 1 |
| Nivargi, S | 1 |
| Yadav, SP | 1 |
| Kasow, KA | 1 |
| Morales-Tirado, VM | 1 |
| Wichlan, D | 1 |
| Shurtleff, SA | 1 |
| Abraham, A | 1 |
| Persons, DA | 1 |
| Riberdy, JM | 1 |
| Zolotovskiĭ, BB | 1 |
| Prostov, IK | 1 |
| Litvinenko, TG | 1 |
4 other studies available for thiotepa and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Successful Allogeneic Stem Cell Transplantation in Nuclear Factor-Kappa B Essential Modulator Deficiency Syndrome After Treosulfan-Based Conditioning: A Case Report.
Topics: Antilymphocyte Serum; Busulfan; Ectodermal Dysplasia; Hematopoietic Stem Cell Transplantation; Human | 2020 |
Reduced-toxicity alternate-donor stem cell transplantation with posttransplant cyclophosphamide for primary immunodeficiency disorders.
Topics: Alemtuzumab; Allografts; Antilymphocyte Serum; Child; Child, Preschool; Cyclophosphamide; Disease-Fr | 2018 |
Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; C | 2011 |
[Role of conditionally pathogenic microbes in the development of experimental destructive pneumonia].
Topics: Animals; Dogs; Escherichia coli Infections; Female; Immunologic Deficiency Syndromes; Lung; Male; Pn | 1981 |